Targeting IRG1 in tumor-associated macrophages for cancer therapy
Open Access
- 18 February 2025
- journal article
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 16 (6) , 478-483
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Itaconate in host inflammation and defenseTrends in Endocrinology & Metabolism, 2024
- Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustionNature Communications, 2023
- Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapyCell Reports, 2023
- Humanized mouse models for immuno-oncology researchNature Reviews Clinical Oncology, 2023
- Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responsesNature Cell Biology, 2022
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugsNature Nanotechnology, 2019
- Humanized immune system mouse models: progress, challenges and opportunitiesNature Immunology, 2019
- Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Nature, 2018
- Lipid Nanoparticle Systems for Enabling Gene TherapiesMolecular Therapy, 2017
- Kit Regulates HSC Engraftment across the Human-Mouse Species BarrierCell Stem Cell, 2014